Cargando…
A reference set of clinically relevant adverse drug-drug interactions
The accurate and timely detection of adverse drug-drug interactions (DDIs) during the postmarketing phase is an important yet complex task with potentially major clinical implications. The development of data mining methodologies that scan healthcare databases for drug safety signals requires approp...
Autores principales: | Kontsioti, Elpida, Maskell, Simon, Dutta, Bhaskar, Pirmohamed, Munir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897500/ https://www.ncbi.nlm.nih.gov/pubmed/35246559 http://dx.doi.org/10.1038/s41597-022-01159-y |
Ejemplares similares
-
Similarity and consistency assessment of three major online drug–drug interaction resources
por: Kontsioti, Elpida, et al.
Publicado: (2022) -
A time-indexed reference standard of adverse drug reactions
por: Harpaz, Rave, et al.
Publicado: (2014) -
A curated and standardized adverse drug event resource to accelerate drug safety research
por: Banda, Juan M., et al.
Publicado: (2016) -
A dataset of 200 structured product labels annotated for adverse drug reactions
por: Demner-Fushman, Dina, et al.
Publicado: (2018) -
A reference set of curated biomedical data and metadata from clinical case reports
por: Caufield, J. Harry, et al.
Publicado: (2018)